Pathogenesis of Myeloma
- 28 February 2011
- journal article
- review article
- Published by Annual Reviews in Annual review of pathology
- Vol. 6 (1), 249-274
- https://doi.org/10.1146/annurev-pathol-011110-130249
Abstract
Multiple myeloma (MM) is a neoplasm of post–germinal center, terminally differentiated B cells. It is characterized by a multifocal proliferation of clonal, long-lived plasma cells within the bone marrow (BM) and associated skeletal destruction, serum monoclonal gammopathy, immune suppression, and end-organ sequelae. MM is preceded by an age-progressive premalignant condition termed monoclonal gammopathy of undetermined significance. Unlike the genomes of most hematological malignancies, and similar to those of solid-tissue neoplasms, MM genomes are typified by numerous structural and numerical chromosomal aberrations as well as mutations in a number of oncogenes and tumor-suppressor genes, some of which have been linked to disease pathogenesis and clinical behavior. Recent studies have also defined the importance of interactions between the MM cells and their BM microenvironment, dysregulation in signaling pathways and in a specialized subpopulation of cells within the tumor (termed myeloma cancer stem cells) for tumor cell growth and survival, and the development of resistance to therapy.Keywords
This publication has 111 references indexed in Scilit:
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewLeukemia, 2009
- Cancer stem cells: controversies in multiple myelomaJournal of Molecular Medicine, 2009
- Cancer stem cells in multiple myelomaCancer Letters, 2008
- IRF4 addiction in multiple myelomaNature, 2008
- The role of microenvironment in tumor angiogenesisGenes & Nutrition, 2008
- AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center MalignanciesCancer Cell, 2008
- Genetic events in the pathogenesis of multiple myelomaBest Practice & Research Clinical Haematology, 2007
- Syndecan-1: a dynamic regulator of the myeloma microenvironmentClinical & Experimental Metastasis, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma PathogenesisCancer Cell, 2007